Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Encouraging phase II data reported for selinexor in gynecological malignancies

June 8, 2015

Scientists disclose phase I results for G-305

June 8, 2015

ATF6 may have a relevant role in the development of achromatopsia

June 8, 2015

Phase III study finds biosimilar BCD-021 equivalent to Avastin in NSCLC

June 8, 2015

ABT-414 shows potential for the treatment of solid tumors

June 5, 2015

ONO-2952, a TSPO antagonist for IBS-D: RESTORE-4 phase II clinical results

June 5, 2015

Sustained responses seen with LY-2951742 in migraineurs

June 5, 2015

Protein disulfide isomerase inhibitors may be used to treat chikungunya virus infection

June 5, 2015

Oncolytic virus therapy with recombinant HSV-1 is efficient for NSGCT treatment

June 4, 2015

Phase I results reported for the small-molecule glutaminase inhibitor CB-839

June 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...